Cat# : THP-0327
| Catalog# | Product Name | Availability | Size | Price | Qty |
|---|---|---|---|---|---|
| THP-0327 | Recombinant Hu-rhEGF-rP64k/Mont Therapeutic Vaccine | April 18, 2024 | 1 vial | $2,998.00 |
|
| Add to Cart Online Order Request a Bulk Order | |||||
| Cat#: | THP-0327 |
| Product Name: | Recombinant Hu-rhEGF-rP64k/Mont Therapeutic Vaccine |
| Description: | Hu-rhEGF-rP64k/Mont is a therapeutic vaccine composed by an antigen (recombinant human EGF (rhEGF) chemically conjugated to recombinant P64K (rP64K)) and an adjuvant (Montanide ISA51VG) being investigated for the treatment of advanced non-small cell lung cancer (NSCLC). |
| Biologic Classification: | Vaccines Conjugate |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2024 Creative BioMart. All Rights Reserved.
